The theme of the Patient BioForum 2025 is From discovery to access: towards a patient-centric health European ecosystem.
The event is hosted by MEP András Tivadar Kulja, who will hold a keynote speech, and concluding remarks will be given by MEP Stine Bosse.
The panel discussion is moderated by Dr. Nicholas Whyte (Senior Director – APCO) and includes:
Rosa Castro (Public Affairs Director, EURORDIS),
Leire Solis, (Health Policy and Advocacy Director, IPOPI),
Solène Jouan (Policy Officer, European Patients’ Forum),
Irene de Cara Torres (Head of Policy and Government Affairs International, CSL Behring),
Dr. Claire Skentelbery (Director General, EuropaBio),
Rainer Becker (Director SANTE.D Medical Products and Innovation).
The event gathers patients organisations, industry leaders and representatives of EU institutions to discuss how the regulatory framework and future legislations (General Pharmaceutical Legislation, EU Biotech Act and Critical Medicines Act) will support innovation, availability, and access to medicines for EU patients.
EuropaBio’s Patient BioForum aims to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations, the biopharmaceutical industry and policy makers.
For more information, please contact Beatrice Rocco: b.rocco@europabio.org
Registrations for people that do not have a badge to access the European Parliament will close at 12:00 on 6 May 2025. People that have a badge can register beyond this date.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.